Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06585579
NA

The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)

Sponsor: Biocodex

View on ClinicalTrials.gov

Summary

This clinical investigation is a post-market clinical follow-up performed to confirm the performance and safety of the Mucogyne® ovule medical device in promoting the process of wound healing, when used in accordance with its approved labelling, in the context of local cervicovaginal surgery.

Official title: ORIGYNE (MUCO232) - the Effect of Mucogyne® Ovule on Wound Healing

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

144

Start Date

2024-10

Completion Date

2025-11

Last Updated

2024-09-05

Healthy Volunteers

No

Interventions

DEVICE

Mucogyne Ovule

In Mucogyne group, patient will receive 2 boxes of Mucogyne® ovule. 24 hours after intervention, the patient will apply Mucogyne® ovule, 1 ovule per day for 10 days, to be repeated as needed (for practices' homogenisation, after the 10th day, it is recommended to apply one ovule every second day, until EOS visit)

Locations (3)

CHU Amiens-Picardie

Amiens, France

CHU Besançon

Besançon, France

Hôpital Nord Franche-Comté

Trévenans, France